Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer von Mock, J N, Costyn, L J, Wilding, S L, Arnold, R D, Cummings, B S

Volltext

Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancerElectronic supplementary information (ESI) ava... von Mock, J. N, Costyn, L. J, Wilding, S. L, Arnold, R. D, Cummings, B. S

Volltext

Once-Weekly Semaglutide in Adults with Overweight or Obesity von Wilding, John P.H, Batterham, Rachel L, Calanna, Salvatore, Davies, Melanie, Van Gaal, Luc F, Lingvay, Ildiko, McGowan, Barbara M, Rosenstock, Julio, Tran, Marie T.D, Wadden, Thomas A, Wharton, Sean, Yokote, Koutaro, Zeuthen, Niels, Kushner, Robert F

Volltext

SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications von Brown, Emily, Heerspink, Hiddo J L, Cuthbertson, Daniel J, Wilding, John P H

Volltext

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trial... von Zelniker, Thomas A, Wiviott, Stephen D, Raz, Itamar, Im, Kyungah, Goodrich, Erica L, Bonaca, Marc P, Mosenzon, Ofri, Kato, Eri T, Cahn, Avivit, Furtado, Remo H M, Bhatt, Deepak L, Leiter, Lawrence A, McGuire, Darren K, Wilding, John P H, Sabatine, Marc S

Volltext

Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus von Kato, Eri T, Silverman, Michael G, Mosenzon, Ofri, Zelniker, Thomas A, Cahn, Avivit, Furtado, Remo H.M, Kuder, Julia, Murphy, Sabina A, Bhatt, Deepak L, Leiter, Lawrence A, McGuire, Darren K, Wilding, John P.H, Bonaca, Marc P, Ruff, Christian T, Desai, Akshay S, Goto, Shinya, Johansson, Peter A, Gause-Nilsson, Ingrid, Johanson, Per, Langkilde, Anna Maria, Raz, Itamar, Sabatine, Marc S, Wiviott, Stephen D

Volltext

Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis von Skyler, Jay S, Bakris, George L, Bonifacio, Ezio, Darsow, Tamara, Eckel, Robert H, Groop, Leif, Groop, Per-Henrik, Handelsman, Yehuda, Insel, Richard A, Mathieu, Chantal, McElvaine, Allison T, Palmer, Jerry P, Pugliese, Alberto, Schatz, Desmond A, Sosenko, Jay M, Wilding, John P H, Ratner, Robert E

Volltext

Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE-TIMI 58 Study von Cahn, Avivit, Mosenzon, Ofri, Wiviott, Stephen D, Rozenberg, Aliza, Yanuv, Ilan, Goodrich, Erica L, Murphy, Sabina A, Bhatt, Deepak L, Leiter, Lawrence A, McGuire, Darren K, Wilding, John P H, Gause-Nilsson, Ingrid A M, Fredriksson, Martin, Johansson, Peter A, Langkilde, Anna Maria, Sabatine, Marc S, Raz, Itamar

Volltext

Cancer Cell Lines for Drug Discovery and Development von WILDING, Jennifer L, BODMER, Walter F

Volltext

The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58 von Mosenzon, Ofri, Wiviott, Stephen D., Heerspink, Hiddo J.L., Dwyer, Jamie P., Cahn, Avivit, Goodrich, Erica L., Rozenberg, Aliza, Schechter, Meir, Yanuv, Ilan, Murphy, Sabina A., Zelniker, Thomas A., Gause-Nilsson, Ingrid A.M., Langkilde, Anna Maria, Fredriksson, Martin, Johansson, Peter A., Bhatt, Deepak L., Leiter, Lawrence A., McGuire, Darren K., Wilding, John P.H., Sabatine, Marc S., Raz, Itamar

Volltext

Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial von Zelniker, Thomas A., Bonaca, Marc P., Furtado, Remo H.M., Mosenzon, Ofri, Kuder, Julia F., Murphy, Sabina A., Bhatt, Deepak L., Leiter, Lawrence A., McGuire, Darren K., Wilding, John P.H., Budaj, Andrzej, Kiss, Robert G., Padilla, Francisco, Gause-Nilsson, Ingrid, Langkilde, Anna Maria, Raz, Itamar, Sabatine, Marc S., Wiviott, Stephen D.

Volltext

Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes... von Zelniker, Thomas A, Wiviott, Stephen D, Raz, Itamar, Im, KyungAh, Goodrich, Erica L, Furtado, Remo H.M, Bonaca, Marc P, Mosenzon, Ofri, Kato, Eri T, Cahn, Avivit, Bhatt, Deepak L, Leiter, Lawrence A, McGuire, Darren K, Wilding, John P.H, Sabatine, Marc S

Volltext

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension von Wilding, John P. H., Batterham, Rachel L., Davies, Melanie, Van Gaal, Luc F., Kandler, Kristian, Konakli, Katerina, Lingvay, Ildiko, McGowan, Barbara M., Oral, Tugce Kalayci, Rosenstock, Julio, Wadden, Thomas A., Wharton, Sean, Yokote, Koutaro, Kushner, Robert F.

Volltext

Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-r... von O'Neil, Patrick M, Birkenfeld, Andreas L, McGowan, Barbara, Mosenzon, Ofri, Pedersen, Sue D, Wharton, Sean, Carson, Charlotte Giwercman, Jepsen, Cecilie Heerdegen, Kabisch, Maria, Wilding, John P H

Volltext

New insights into the treatment of obesity von Blüher, Matthias, Aras, Mohini, Aronne, Louis J., Batterham, Rachel L., Giorgino, Francesco, Ji, Linong, Pietiläinen, Kirsi H., Schnell, Oliver, Tonchevska, Elena, Wilding, John P.H.

Volltext

Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus von Berg, David D., Wiviott, Stephen D., Scirica, Benjamin M., Gurmu, Yared, Mosenzon, Ofri, Murphy, Sabina A., Bhatt, Deepak L., Leiter, Lawrence A., McGuire, Darren K., Wilding, John P.H., Johanson, Per, Johansson, Peter A., Langkilde, Anna Maria, Raz, Itamar, Braunwald, Eugene, Sabatine, Marc S.

Volltext

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial von Mosenzon, Ofri, Wiviott, Stephen D, Cahn, Avivit, Rozenberg, Aliza, Yanuv, Ilan, Goodrich, Erica L, Murphy, Sabina A, Heerspink, Hiddo J L, Zelniker, Thomas A, Dwyer, Jamie P, Bhatt, Deepak L, Leiter, Lawrence A, McGuire, Darren K, Wilding, John P H, Kato, Eri T, Gause-Nilsson, Ingrid A M, Fredriksson, Martin, Johansson, Peter A, Langkilde, Anna Maria, Sabatine, Marc S, Raz, Itamar

Volltext

Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years von Wilding, J. P. H., Woo, V., Rohwedder, K., Sugg, J., Parikh, S.

Volltext

Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial von Furtado, Remo H.M., Raz, Itamar, Goodrich, Erica L., Murphy, Sabina A., Bhatt, Deepak L., Leiter, Lawrence A., McGuire, Darren K., Wilding, John P.H., Aylward, Philip, Dalby, Anthony J, Dellborg, Mikael, Dimulescu, Doina, Nicolau, José C., Oude Ophuis, Anthonius J.M., Cahn, Avivit, Mosenzon, Ofri, Gause-Nilsson, Ingrid, Langkilde, Anna Maria, Sabatine, Marc S., Wiviott, Stephen D.

Volltext

Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes: Post Hoc Analyses From the DECLARE-TIMI 58 Trial von Mosenzon, Ofri, Raz, Itamar, Wiviott, Stephen D, Schechter, Meir, Goodrich, Erica L, Yanuv, Ilan, Rozenberg, Aliza, Murphy, Sabina A, Zelniker, Thomas A, Langkilde, Anna Maria, Gause-Nilsson, Ingrid A M, Fredriksson, Martin, Johansson, Peter A, Wilding, John P H, McGuire, Darren K, Bhatt, Deepak L, Leiter, Lawrence A, Cahn, Avivit, Dwyer, Jamie P, Heerspink, Hiddo J L, Sabatine, Marc S

Volltext